These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice. Dandiya PC; Bhargava LP Arch Int Pharmacodyn Ther; 1968 Nov; 176(1):157-67. PubMed ID: 5709781 [No Abstract] [Full Text] [Related]
3. [ON THE MECHANISM OF ACTION OF MONOAMINE OXIDASE INHIBITORS]. HORNYKIEWICZ O Wien Klin Wochenschr; 1964 Apr; 76():289-93. PubMed ID: 14223504 [No Abstract] [Full Text] [Related]
4. An operational evaluation of monoamine oxidase inhibitors. Blackwell B; Taylor D Proc R Soc Med; 1967 Aug; 60(8):830-4. PubMed ID: 6035423 [No Abstract] [Full Text] [Related]
5. Effects of monoamine oxidase inhibitors on isoproterenol-induced cardiomegaly in rats. Stanton HC; Bowman Z; Cooper CM Toxicol Appl Pharmacol; 1970 Jan; 16(1):256-63. PubMed ID: 4244547 [No Abstract] [Full Text] [Related]
6. Antianginal drugs. V. Monoamine oxidase (MAO) inhibitors. Fisch S Am Heart J; 1966 Jun; 71(6):837-8. PubMed ID: 5945147 [No Abstract] [Full Text] [Related]
7. Some antagonists of the monoamine oxidase inhibitors. HORITA A Ann N Y Acad Sci; 1963 Jul; 107():951-7. PubMed ID: 13954907 [No Abstract] [Full Text] [Related]
8. Monoamine oxidase inhibitors revisited: what you should know. Goldberg JF; Thase ME J Clin Psychiatry; 2013 Feb; 74(2):189-91. PubMed ID: 23473352 [No Abstract] [Full Text] [Related]
10. MAO inhibition and antidepressant activity. Feldstein A; Hoagland H; Rivera Oktem M; Freeman H Int J Neuropsychiatry; 1965 Aug; 1(4):384-7. PubMed ID: 5324597 [No Abstract] [Full Text] [Related]
11. MONOAMINE OXIDASE INHIBITORS. ADVERSE REACTIONS AND POSSIBLE MECHANISMS. GOLDBERG LI JAMA; 1964 Nov; 190():456-62. PubMed ID: 14197995 [No Abstract] [Full Text] [Related]
12. Relative activity of some inhibitors of mono-amine oxidase in potentiating the action of tryptamine in vitro and in vivo. MAXWELL DR; GRAY WR; TAYLOR EM Br J Pharmacol Chemother; 1961 Dec; 17(3):310-20. PubMed ID: 14471627 [TBL] [Abstract][Full Text] [Related]
13. Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats. Stanton HC; Schwartz A Proc West Pharmacol Soc; 1966; 9():6-8. PubMed ID: 4381147 [No Abstract] [Full Text] [Related]
14. MAOIs in the contemporary treatment of depression. Thase ME; Trivedi MH; Rush AJ Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154 [TBL] [Abstract][Full Text] [Related]
16. A neglected modality in psychiatric treatment--the monoamine oxidase inhibitors. Johnson WC Dis Nerv Syst; 1975 Sep; 36(9):521-5. PubMed ID: 1175468 [TBL] [Abstract][Full Text] [Related]
17. The antagonism of hydrazine-type inhibitors of monoamine oxidase by sodium pyruvate. HORITA A; MATSUMOTO C Life Sci (1962); 1962 Oct; 1():491-501. PubMed ID: 13954904 [No Abstract] [Full Text] [Related]
18. Antidepressants: comparison of clinical effects in anergic schizophrenia and the depressed states. SCHIELE BC Ann N Y Acad Sci; 1963 Jul; 107():1131-8. PubMed ID: 13991665 [No Abstract] [Full Text] [Related]
19. Effect of inhibitors of monoamine oxidase on various enzymes and on the storage of monoamines. GEY KF; PLETSCHER A; BURKARD W Ann N Y Acad Sci; 1963 Jul; 107():1147-51. PubMed ID: 13947443 [No Abstract] [Full Text] [Related]
20. CHEESE AND MONOAMINE OXIDASE INHIBITORS. INTERACTION IN ANAESTHETISED CATS. NATOFF IL Lancet; 1964 Mar; 1(7332):532-3. PubMed ID: 14100189 [No Abstract] [Full Text] [Related] [Next] [New Search]